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.Lead A r i i c i e 
Primary Hyperparathyroidism: 
The Continuing Saga of Surgical Problemst 
Melvin A. Block, MD' 
Cont/nu;ng problems in the management and surgical 
treatment of primary hyperparathyroidism include the 
localization ofthe elusive single tumor, the recognition 
and management of multiple gland involvement, prompt 
confirmation and operative treatment for hypercalcemic 
crisis, delineation ofa liberal but selective policy relative 
to surgery for apparent uncomplicated hyperparathy-
roidism in the elderly, and recognition ofthe surgeon's 
responsibility to determine the extent of the operation 
on the basis of operative findings, realizing that histo-
logic study may not confirm apparent gross abnormali-
ties despite subsequent clinical recovery. When all four 
glands are involved in primary hyperparathyroidism, 
subtotal parathyroidectomy is recommended except for 
patients with multiple endocrine neoplasia, type I (MEN 
I), in which cases, with great enlargement of all glands, 
total parathyroidectomy and autotransplantation appear 
justified. Selective removal of parathyroid glands is indi-
cated for multiple involvement affecting fewer than four 
glands. Recent experience emphasizes the importance 
of benign familial hypocalciuric hypercalcemia, the late 
appearance of primary hyperparathyroidism after radia-
tion therapy to the neck, and the association of primary 
hyperparathyroidism with a number of other clinical 
entities. 
T h i s discussion of certain cont inuing and several newer 
problems of primary hyperparathyroidism is derived 
f rom over 25 years of experience with approximately 350 
patients at Henry Ford Hospital and with 38 patients in 
the past two years at the Scripps Clinic. 
Continuing Problems 
The elusive single tumor 
The single, enlarged parathyroid gland, which is respon-
sible for primary hyperparathyroidism in approximately 
85% of patients, is sometimes discovered in unusual 
locations. Knowledge of the normal anatomy of the 
neck and upper mediastinum along with awareness of 
the unusual locations of these glands is essential for the 
parathyroid surgeon (1). Missed enlarged parathyroid 
glands should besought in several locations: deep in the 
sternoclavicular joint area, high in the neck (unde-
scended), associated with the thymus in the anterior 
superior mediastinum (but accessible through a neck 
incision), deep in the neck associated with the fascia 
over the cervical vertebrae, or intimately associated with 
the thyroid gland, from which delineation is quite 
diff icult. 
Whi le future refinement of non-invasive procedures, 
such as ultrasonography, may help to identify elusive 
parathyroid tumors, currently available instruments are 
not reliable in problem cases (2). Invasive studies, espe-
cially angiography, are valuable in locating parathyroid 
tumors but carry risks, especially neurologic complica-
tions. Moreover, the cost of angiography justifies its use 
for patients in whom initial exploration of the parathy-
roid glands was unsuccessful (3). The same difficulties 
characterize selective cervical venous sampling for para-
thyroid hormone assay as a method for localizing hyper-
funct ioning parathyroid tumors (4). 
t i h i s paper was presented a l l h e First Plenary Session of the Henry Ford Hospilal 
1982 A lumn i Reunion on Oc lober 21,1982. 
Submit ted for publ icat ion: Oc tober 14,1982 
Accepted for publ icat ion: lanuary 3,1983 
'Depa r tmen t of Surgery, Scripps Clinic and Researcti Foundat ion, ta lo l la , 
Cali fornia 
Address reprint requests lo Dr. Block, Departmenl of Surgery. Scripps Clinic and 
Research Foundat ion, 10666 N. Torrey Pines, La lo l la , CA 92037 
181 
Block 
Although the mediastinal location of hyperfunctioning 
parathyroid glands is rare (less than 1%), the surgeon 
should be prepared to explore the mediastinum for a 
missed parathyroid tumor not identif ied by preopera-
tive studies. At this t ime, computerized tomography can 
identify about 50% of parathyroid tumors lying deep in 
the mediastinum (5,6). Al though this record justifies its 
use preoperatively, particularly in patients with increased 
risk for operation or reoperation, the CT scan is not 
entirely reliable. Arteriography is more accurate than 
other studies in detecting mediastinal parathyroid tum-
ors (7), but associated risks require selectivity in its use. 
Reoperation carries a substantial risk of inducing per-
manent hypoparathyroidism. The extent of the loss of 
parathyroid tissue consequent to the first operation may 
be unknown, and the need to dissect through scar tissue 
jeopardizes whatever normai parathyroid tissue remains 
(8). The decision to perform immediate autotransplanta-
t ion of the parathyroid tissue or to freeze the tissue for 
possible later autotransplantation must be based on sev-
eral factors of surgical judgment: whether or not the 
remaining parathyroid tissue is viable; whether or not 
the parathyroid tumor that produced hyperparathyroid-
ism has been removed; whether or not the parathyroid 
tissue available for autotransplantation is normal. The 
elusive parathyroid tumor may be a supernumerary 
gland, and it may be found in an unusual location such as 
the mediastinum. Supernumerary glands reportedly are 
predisposed for location in the anterior superior medi-
astinum or in the more caudal mediastinum (9). 
Recognition and management of multiple 
parathyroid gland involvement 
Primary hyperparathyroidism with mult iple parathyroid 
gland involvement can be categorized into two major 
entities (10): all parathyroid glands enlarged and hyper-
plastic; less than four glands enlarged and hyperplastic 
(11,12). In both categories,thedegreeof enlargement of 
the gland varies greatly, f rom slight enlargement of all 
involved glands, to great enlargement of some and slight 
enlargement of others in a single patient, to great 
enlargement o fa l l involved glands. 
The surgeon treating primary hyperparathyroidism with 
mult iple parathyroid gland involvement encounters 
three major problems: 
1. Failure to recognize the presence of mult iple 
gland involvement. As a result, only one para-
thyroid gland is removed and hyperparathyroid-
ism persists. 
2. Failureto identify all involved parathyroid glands, 
so that the remaining hyperfunctioning glands 
cause persistent hyperparathyroidism. The re-
maining hyperfunctioning gland may be super-
numerary. 
3. Production of permanent hypoparathyroidism. 
Extensive dissection necessary to identify all 
parathyroid glands and the removal of more 
parathyroid tissue than needed (because of dif-
ficulty in judging at operation the number of 
involved glands) may cause permanent parathy-
roid deficiency. 
Primary hyperparathyroidism with involvement of all 
glands has certain unique features. Among these is the 
association with mult iple endocrine neoplasia (MEN) 
syndromes. Not all hyperparathyroid patients with 
involvement of all parathyroid glands have the MEN 
syndrome, but all patients with a MEN syndrome and 
primary hyperparathyroidism have all parathyroid glands 
involved. Primary hyperparathyroidism is characteristic 
of all patients with MEN I syndrome, of some patients 
w i thMEN l lasyndrome, but of no patients with MEN l ib 
(13,14). 
Whenever mult iple parathyroid gland involvement is 
recognized in primary hyperparathyroidism, family mem-
bers should be screened for the disease. The extent of 
involvement in familial hyperparathyroidism can be 
predictedasfol lows: 1) inMEN II andMEN l lasyndrome 
patients, all parathyroid glands are involved; 2) in 
approximately 40% of patients with non-MEN familial 
primary hyperparathyroidism, all parathyroid glands are 
involved, and the same disorder occurs in all family 
members. The number of involved parathyroid glands 
varies in the other60% of patients, but usually morethan 
one gland is hyperfunctioning. 
The best surgical management for primary hyperpara-
thyroidism with all parathyroid glands involved remains 
controversial. Some advocate subtotal parathyroidec-
tomy with preservation of 30-50 mg viable parathyroid 
tissue, whi le others recommend total parathyroidec-
tomy and autotransplantation of parathyroid tissue (15-
19). For patients who have fewer than four involved 
parathyroid glands, the objective must be to remove all 
involved tissue short of total parathyroidectomy (15,20). 
Results of this procedure are excellent. However, when 
all parathyroid glands are involved, no currently avail-
able operative procedures are successful in all cases.The 
expected results for surgical treatment (Table 1) can be 
summarized in the fol lowing way. 
Because the reported long-term recurrence rate after 
subtotal parathyroidectomy is approximately 50% in 
patients with MEN I syndrome(15,18), total parathyroid-
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TABtE 1 
Primary Hyperparathyroidism Due to Mu l t ip le Gland Involvement: 
Results of Operative Procedures 
Report 
1. Subtotal parathyroiidectomy 
Edis, et al (16) 
Wang, et al (17) 
Block, et al (15) 
Prinz, et al (18) 
11. Total parathyroidectomy, 
autotransplantation 
Wells, et al (19) 
(for all gland involvement) 
% Persistence or Recurrence 
14 
4 
14±(50% MEN; 
8% non-MEN) 
33 in MEN I 
8 (30% later 
hypercalcemic) 
ectomy with autotransplantation appears justified for 
young patients with the syndrome. This is particularly 
indicated for MEN I patients in whom all parathyroid 
glands are greatly enlarged. However, Wells, et al 
reported a recurrence of hypercalcemia in 30% of the 
patient group so treated (19). Accordingly, this group of 
patients must be fol lowed indefinitely. If recurrent 
hyperparathyroidism does occur, additional transplanted 
parathyroid tissue is readily removed f rom the forearm. 
For patients other than those with MEN I who have 
primary hyperparathyroidism involving all parathyroid 
glands, subtotal parathyroidectomy is the preferred 
treatment (10,15,17). The early success rate of both sub-
total parathyroidectomy and total parathyroidectomy 
with autotransplantation approximates 92%, but a period 
of hypoparathyroidism always occurs in the latter pro-
cedure and is permanent in a few (19). The ultimate 
recurrence rate of hypercalcemia due to hyperplasia of 
autotransplanted parathyroid tissue may be higher than 
after subtotal parathyroidectomy. 
Acute hypercalcemic crisis 
Acute hypercalcemic crisis usually occurs in elderly 
patients who frequently have other serious problems 
that confuse the diagnosis and complicate treatment. In 
the elderly, toxicity can occur with only modest eleva-
tions of serum calcium (13-14 mgm%). The mental 
depression associated with hypercalcemic crisis was a 
particular problem in two elderly patients in our recent 
experience, both of whom had evidence of severe 
hypercalcemia and large intracranial meningiomas. In 
one patient, age 71, whose condit ion was characterized 
by acute mental depression, a serum calcium level as 
high as 18.3 mgm%, a huge intracranial meningioma, 
and gait disturbance, removal of the meningioma only 
temporari ly improved symptoms; but removal ofa para-
thyroid tumor produced a slow but definite return to 
normalcy. Another patient, age 70 years, whose serum 
calcium level increased from 10.8 to 12.5 mgm% over six 
months, developed acute mental confusion and was 
found to have a large anterior falx meningioma. Remo-
val of the meningioma dramatically improved the 
patient's mental status, but continued hypercalcemia 
required parathyroid surgery. 
In general, management of patients wi th evidence of 
acute hypercalcemic crisis involves evaluation of the 
diagnosis by chest x-ray, intravenous pyelogram, deter-
mination of serum protein levels and bone marrow 
cytology, and clinical examination to uncover malig-
nancy or other causes of hypercalcemia (21,22). When 
hyperparathyroidism remains the presumptive diagno-
sis, the serum calcium level is reduced by administration 
of mithramycin and other measures. Exploration o f t h e 
parathyroid glands is performed, usually within 72 hours, 
to provide definite treatment (21,22). 
Uncomplicated primary hyperparathyroidism 
in the elderly 
Management of primary hyperparathyroidism in the 
elderly is a continuing problem. In some series approxi-
mately one third of patients with primary hyperparathy-
roidism are over 65 years ofage; ofthese, more than 50% 
had no evidence of either renal or bone complications 
(23). The Mayo Clinic study of uncomplicated primary 
hyperparathyroidism (24) failed to provide definite guides 
for management of these patients. 
Surgical correction of primary hyperparathyroidism in 
the elderly appears justified when the disorder is asso-
ciated with mental depression and weakness, and the 
patient's health is adequate to undertake the low risk of 
exploration o f the parathyroid glands (23). Correction of 
hypercalcemia may permit elderly bedridden patients to 
become active. The possibility that continued elevation 
of serum calcium may produce a hypercalcemic crisis 
requires that such patients be monitored every three to 
four months unless the problem has been corrected. On 
the other hand, with serious cardiovascular or pulmo-
nary insufficiency even the low operative risk of parathy-
roid exploration may be excessive to correct mild to 
moderately severe hyperparathyroidism (25). 
Confusing clinical pathologic correlations 
Discrepancies exist between the microscopic findings, 
the gross evidence of disease, and the clinical manifesta-
t ion of hyperparathyroidism (11,12). These include the 
lack of correlation between microscopic findings, i.e., 
adenoma versus hyperplasia, and the gross evidence of 
single versus mult iple gland involvement. Moreover, in 
some cases the correlation between microscopic f ind-
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ings, the size of parathyroid tumor, and the clinical 
response to surgery is obscure. 
It is well recognized, although not always respected, that 
pathologists f ind it diff icult to differentiate between 
adenoma and hyperplasia and thereby to distinguish 
between single and mult iple parathyroid gland involve-
ment. The terms "single and mult iple gland involve-
ment " or "parathyroid tumor " are held to be more 
informative than "adenoma" or "hyperplasia" in char-
acterizing the pathologic anatomy of primary hyperpara-
thyroidism. In this regard, studies by Fialhow and col-
leagues indicatethat primary hyperparathyroidism ofal l 
varieties has a multicellular rather than a single cellular 
origin (26). 
Another discrepancy between pathologic and clinical 
findings relates to the significance of the fat content of 
parathyroid glands in determining abnormality. In four 
of our patients whose glands were enlarged by weight 
(59 to 95 mgm) and in whom hypercalcemia was cor-
rected by removing the glands, the presence of consid-
erable quantities of fat led to a pathologist's report of 
normal parathyroid tissue. Thus, in the presence of fat 
cells, enlarged glands may be characterized as micro-
scopically normal even though other evidence indicates 
abnormality. In our series, we removed parathyroid 
glands weighing 95,90,71, and 59 mgm from four differ-
ent patients and permanently corrected the hyper-
calcemia, but the pathologist described the glands as 
normal. Al l had very high fat content. This problem 
tends to occur in elderly patients particularly. More 
detailed study can confirm the increased funct ioning 
tissue in these glands with variable fat content (27,28). 
The hyperplasia found in patients with benign hypocal-
ciuric hypercalcemia is another unclear issue of parathy-
roid pathology. In addition, fragments of parathyroid 
tissue are often found in adipose tissue surrounding a 
parathyroid gland, whether it is normal or enlarged and 
hyperfunctioning. These variables are not resolved by 
tests that depend on density or similar measurements to 
separate hyperfunctioning from normal parathyroid 
glands or other tissue (29). Measuring the weight and 
dimensions of a parathyroid gland is important gross 
evidence of pathologic significance (11,12). 
New Experiences 
Recognizing benign familial hypocalciuric hypercalcemia 
In 1966, Jackson and colleagues (30) recognized the 
occurrence of familial hypercalcemia which failed to 
respond to standard treatment, and most large series of 
patients contained similar examples. Marx and col-
leagues (31,32) have defined benign familial hypocalciu-
ric hypercalcemia as an entity of clinical significance. 
Essential clinical features include the presence of life-
long hypercalcemia at all ages, lack of relationship to 
MEN syndromes, a confusing elevation of serum para-
thyroid hormone levels, absence of clinical complica-
tions (except possibly pancreatitis in rare instances), and 
serious clinical manifestations in infants with hypotonia 
and skeletal undermineralization, which can justify total 
parathyroidectomy. 
The parathyroid glands vary in size and, microscopically, 
are considered to be hyperplastic. Subtotal parathyroid-
ectomy does not permanently correct the hypercalcemia. 
Benign familial hypocalciuric hypercalcemia occursoften 
enough to justify its consideration whenever uncompl i -
cated hypercalcemia is recognized. This entity has been 
recognized primarily as a result of the routine serum 
calcium determinations performed with increasing fre-
quency in recent years. In patients with uncomplicated 
primary hyperparathyroidism who have no renal or 
skeletal complications, the diagnosis of benign familial 
hypocalciur ic hypercalcemia may be conf i rmed by 
demonstration of urinary calcium levelsoflOO mgor less 
per 24 hours, a calcium/creatinine clearance ratio of less 
than 0.010, and familial occurrence of the disorder (31). 
Serum parathyroid hormone levels are not of diagnostic 
significance. 
Because in this entity complications of the hypercalce-
mia do not occur, other family members must be studied 
to identify the familial presence. As far as can now be 
ascertained, treatment is unnecessary for adults. 
Confusing variations do occur in benign familial hypo-
calciuric hypercalcemia. We have encountered one fam-
ily in whom subtotal parathyroidectomy reduced the 
serum calcium to normal levels at least for some months. 
Because some patients have enlarged parathyroid glands, 
the findings at surgery are not different f rom those of 
primary hyperparathyroidism. There is a reported 15% 
overlap in calcium/creatinine clearance ratios between 
patients with primary hyperparathyroidism and those 
with benign familial hypocalciuric hypercalcemia (32). 
Late appearance of primary hyperparathyroidism after 
external radiation therapy 
While I was at Henry Ford Hospital, I first suspected that 
an etiologic relationship exists between primary hyper-
parathyroidism and external radiation therapy to the 
head and neck. Our studies at the hospital conf irmed 
the statistical significance of the relationship (33). Our 
original studies suggested that in these patients primary 
hyperparathyroidism usually occurs late, decades after 
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radiation, and our experience in the past two years sup-
ports this observation. 
In this time we have successfully operated on four 
patients for primary hyperparathyroidism 45,34,27, and 
26 years after they had received external radiation ther-
apy to the neck. Hyperparathyroidism had occurred in 
two of these patients 28 and 30 years after operation for 
thyroid neoplasms, and total thyroidectomy was neces-
sary in one patient. In a f i f th patient in whom we per-
formed total thyroidectomy for a papillary thyroid carci-
noma 25 years after he had received external radiation 
therapy to the neck, we encountered at operation an 
enlarged parathyroid gland weighing 66 mgm. Histo-
logic study disclosed mild parathyroid hyperplasia. In 
this patient the preoperative serum calcium level of 10.1 
mgm/d l (normal, 8.7-10.2) fell postoperatively to 7.0 
mgm/d l before rapidly returning to normal (9.7 mgm/dl) . 
We believe that hyperfunction was developing in this 
parathyroid gland and that hypercalcemia would even-
tually have occurred. Prinz and associates have reported 
a similar experience (34). 
Another patient, 61 years o ld, developed evidence of 
primary hyperparathyroidism seven years after receiving 
high dose external radiation fortherapy of carcinoma of 
the larynx. Two enlarged parathyroid glands weighingl gm 
and 95 mgm were removed, correcting the hypercalcemia. 
Recently reported evidence implicates radioactive iodine 
therapy administered for treatment of hyperthyroidism 
as a factor in the late occurrence of primary hyperpara-
thyroidism (35). Of 854 patients treated for primary 
hyperparathyroidism at the Cleveland Clinic, four had 
received radioactive iodine therapy, in three patients 
more than 20 years earlier and in one patient, six years 
earlier. The expected late incidence of primary hyper-
parathyroidism in patients receiving radioactive iodine 
therapy was estimated to be one in 800-900 patients. In 
addi t ion, eight of 160 patients who were under 18 years 
of age when treated with radioactive iodine were found 
subsequently to have hypercalcemia, probably due to 
primary hyperparathyroidism. 
Single gland enlargement is the usual f inding in patients 
with primary hyperparathyroidism fol lowing external 
radiation therapy. However, these patients should be 
fol lowed for possible recurrent primary hyperparathy-
roidism in the remaining glands. Moreover, it is recom-
mended that patients receiving radiation therapy to the 
neck region be screened periodicaliy for developing 
hypercalcemia. Certainly, surgeons should carefully eval-
uate the parathyroid glands when they operate for thy-
roid neoplasms, especially in patients who have received 
previous radiation therapy to the neck region. Removal 
of enlarged parathyroid glands seems justified. 
Miscellaneous MEN syndromes 
Combinations of primary hyperparathyroidism and other 
endocrine disease occur sporadically (36). In our patients 
with primary hyperparathyroidism, we have encoun-
tered coexisting non-functioning islet cell carcinoma, 
acromegaly, and unilateral aldosteronoma, all appar-
ently non-hereditary. Primary hyperparathyroidism has 
been associated with pheochromocytomas, although 
these tumors can themselves be the cause of hyper-
calcemia (37,38). Occurrence of primary hyperparathy-
roidism with other endocrine tumors can be simultane-
ous, or either may precede the other. The question of 
which endocrine tissue is responsible for the hyper-
calcemia can be resolved by the demonstration of ele-
vated parathyroid hormone levels in blood obtained 
selectively from neck veins. Parathyroid carcinoma, a 
rare lesion, occurs in families more than is to be 
expected for random distribution (39). This might be 
considered as MEN III. 
Primary hyperparathyro'idism may occur in association 
with other disease processes which by themselves can 
produce hypercalcemia. Examples are the simultaneous 
occurrence of primary hyperparathyroidism and malig-
nancies such as breast and renal carcinoma, sarcoidois, 
or mult iple myeloma (40-43). 
TABLE II 
Primary Hyperparathyroidism: Reasons for Failed Operat ion 
1. Erroneous diagnosis 
Malignancy, other causes for hypercalcemia, medications 
Benign familial hypocalciuric hypercalcemia 
2. Failure to identify elusive single tumor 
Anterior superior mediastinum, under sternoclavicular junct ion 
High in neck (undescended) 
Intrathyroid 
Mediast inum 
Carotid sheath 
3. Failure to perform adequate operat ion for mult iple gland involve-
ment (removal of mul t ip le but less than four enlarged glands, 
subtota l pa ra thy ro idec tomy , to ta l pa ra thy ro idec tomy w i th 
autotransplantation) 
4. Supernumerary parathyroid tumor (usually located inferiorly) 
5. Cont inued st imulation of remaining parathyroid tissue after sub-
total para thyro idec tomy or total parathyro idectomy w i th 
autotransplantation 
6. Complications of hypoparathyroidism 
Preserved remnant not viable or inadequate 
Excess removal of glands 
Suppressed remaining parathyroid tissue incapable of ade-
quate funct ion 
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Parathyroid cysts 
Parathyroid cyst manifested as a palpable nodule in the 
anterior neck is a rare lesion recognized in recent years. 
These cysts are frequently thought to be thyroid nodules, 
particularly when a defect is produced in a thyroid scan. 
Needle aspiration biopsy and ultrasound studies which 
identify the cystic nature of this entity can identify para-
thyroid cysts wi thout the need for operation. In our 
experience aspiration is curative. 
Parathyroid cysts usually occur in young women. When 
aspiration of f lu id, either clear and opalescent or thin 
and blood-t inged, results in complete disappearance of 
the nodule, the probable diagnosis is a simple parathy-
roid cyst. A high level of parathyroid hormone in the cyst 
f luid is confirmatory. 
Simple parathyroid cysts should be distinguished from 
parathyroid tumors with cystic degeneration. Al though 
simple cysts usually contain small fragments of parathy-
roid tissue in their wall, they probably are not formed by 
cystic degeneration of parathyroid tumors. Clinical hyper-
parathyroidism has not been reported in a patient with a 
single parathyroid cyst, although it certainly occurs in 
patients with cystic degenerating parathyroid tumors. 
Overall Results of Operation for 
Primary Hyperparathyroidism 
Although a number of factors can lead to a failed opera-
t ion for primary hyperparathyroidism (Table II), results 
of surgical management are good. The overall success 
rate is 95-97% (Table III) with a very low incidence of 
complications (10,15,17,44). 
TABLE III 
Primary Hyperparathyroidism: Overal l Results of Surgery 
I. Overall Success—95-97% (20,44) 
II . Complications 
Procedures Persistence or Permanent 
Late Recurrence Hypoparathyroidism 
Major 
Complicat ions 
Removal—single 
gland involved 
(20,44) 
Subtotal 
parathyroidectomy 
for mult ip le 
gland involvement 
(15,18) 
1";. 
MEN 1 ± 50% 
non-MEN 8% 
0.5% 
3.4% 
+ 1 % 
± 1 % 
Morta l i ty 
0% 
0% 
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